カテゴリー： QYResearch, 世界

世界のホスホジエステラーゼ（PDE）阻害剤産業：成長傾向・競合分析2019-2025

【英語タイトル】Global Phosphodiesterase (PDE) inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料（DATA909X01764）・商品コード：DATA909X01764
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：118
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥725,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,087,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,450,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートでは、世界のホスホジエステラーゼ（PDE）阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ホスホジエステラーゼ（PDE）阻害剤の種類別には、PDE1選択的阻害剤、PDE2選択的阻害剤、PDE3選択的阻害剤、PDE4選択的阻害剤、PDE5選択的阻害剤、PDE7選択的阻害剤、PDE10選択的阻害剤に、用途別には、経口、局所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・ホスホジエステラーゼ（PDE）阻害剤の種類別市場規模：PDE1選択的阻害剤、PDE2選択的阻害剤、PDE3選択的阻害剤、PDE4選択的阻害剤、PDE5選択的阻害剤、PDE7選択的阻害剤、PDE10選択的阻害剤
・ホスホジエステラーゼ（PDE）阻害剤の用途別市場規模：経口、局所、その他
・ホスホジエステラーゼ（PDE）阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：Bayer AG、Eli Lilly and Co.、GlaxoSmithKline Plc、Pfizer Inc.、Vivus Inc.
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s). PDE inhibitor drugs are also used to treat various other medical conditions such as autoimmune indications, ulcerative colitis, and others. However, the increasing incidence of ED across the world will boost the global phosphodiesterase inhibitors market growth during the forecast period.
In 2018, the global Phosphodiesterase (PDE) inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Phosphodiesterase (PDE) inhibitors.

This study researches the market size of Phosphodiesterase (PDE) inhibitors, presents the global Phosphodiesterase (PDE) inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Phosphodiesterase (PDE) inhibitors in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Phosphodiesterase (PDE) inhibitors for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Eli Lilly and Co.
GlaxoSmithKline Plc
Pfizer Inc.
Vivus Inc.
…

Market Segment by Product Type
PDE1 Selective Inhibitors
PDE2 Selective Inhibitors
PDE3 Selective Inhibitors
PDE4 selective inhibitors
PDE5 selective inhibitors
PDE7 selective inhibitors
PDE10 selective inhibitors

Market Segment by Application
Oral
Topical
Other

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Phosphodiesterase (PDE) inhibitors status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Phosphodiesterase (PDE) inhibitors manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Phosphodiesterase (PDE) inhibitors are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Phosphodiesterase (PDE) inhibitors Market Size Growth Rate by Type
1.3.2 PDE1 Selective Inhibitors
1.3.3 PDE2 Selective Inhibitors
1.3.4 PDE3 Selective Inhibitors
1.3.5 PDE4 selective inhibitors
1.3.6 PDE5 selective inhibitors
1.3.7 PDE7 selective inhibitors
1.3.8 PDE10 selective inhibitors
1.4 Market Segment by Application
1.4.1 Global Phosphodiesterase (PDE) inhibitors Market Share by Application (2019-2025)
1.4.2 Oral
1.4.3 Topical
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Phosphodiesterase (PDE) inhibitors Market Size
2.1.1 Global Phosphodiesterase (PDE) inhibitors Revenue 2014-2025
2.1.2 Global Phosphodiesterase (PDE) inhibitors Sales 2014-2025
2.2 Phosphodiesterase (PDE) inhibitors Growth Rate by Regions
2.2.1 Global Phosphodiesterase (PDE) inhibitors Sales by Regions 2014-2019
2.2.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Phosphodiesterase (PDE) inhibitors Sales by Manufacturers
3.1.1 Phosphodiesterase (PDE) inhibitors Sales by Manufacturers 2014-2019
3.1.2 Phosphodiesterase (PDE) inhibitors Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Phosphodiesterase (PDE) inhibitors Revenue by Manufacturers (2014-2019)
3.2.2 Phosphodiesterase (PDE) inhibitors Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Phosphodiesterase (PDE) inhibitors Market Concentration Ratio (CR5 and HHI)
3.3 Phosphodiesterase (PDE) inhibitors Price by Manufacturers
3.4 Key Manufacturers Phosphodiesterase (PDE) inhibitors Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Phosphodiesterase (PDE) inhibitors Market
3.6 Key Manufacturers Phosphodiesterase (PDE) inhibitors Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 PDE1 Selective Inhibitors Sales and Revenue (2014-2019)
4.1.2 PDE2 Selective Inhibitors Sales and Revenue (2014-2019)
4.1.3 PDE3 Selective Inhibitors Sales and Revenue (2014-2019)
4.1.4 PDE4 selective inhibitors Sales and Revenue (2014-2019)
4.1.5 PDE5 selective inhibitors Sales and Revenue (2014-2019)
4.1.6 PDE7 selective inhibitors Sales and Revenue (2014-2019)
4.1.7 PDE10 selective inhibitors Sales and Revenue (2014-2019)
4.2 Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type
4.3 Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Type
4.4 Phosphodiesterase (PDE) inhibitors Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Phosphodiesterase (PDE) inhibitors Sales by Application

6 North America
6.1 North America Phosphodiesterase (PDE) inhibitors Breakdown Data by Company
6.2 North America Phosphodiesterase (PDE) inhibitors Breakdown Data by Type
6.3 North America Phosphodiesterase (PDE) inhibitors Breakdown Data by Application
6.4 North America Phosphodiesterase (PDE) inhibitors Breakdown Data by Countries
6.4.1 North America Phosphodiesterase (PDE) inhibitors Sales by Countries
6.4.2 North America Phosphodiesterase (PDE) inhibitors Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Phosphodiesterase (PDE) inhibitors Breakdown Data by Company
7.2 Europe Phosphodiesterase (PDE) inhibitors Breakdown Data by Type
7.3 Europe Phosphodiesterase (PDE) inhibitors Breakdown Data by Application
7.4 Europe Phosphodiesterase (PDE) inhibitors Breakdown Data by Countries
7.4.1 Europe Phosphodiesterase (PDE) inhibitors Sales by Countries
7.4.2 Europe Phosphodiesterase (PDE) inhibitors Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Phosphodiesterase (PDE) inhibitors Breakdown Data by Company
8.2 Asia Pacific Phosphodiesterase (PDE) inhibitors Breakdown Data by Type
8.3 Asia Pacific Phosphodiesterase (PDE) inhibitors Breakdown Data by Application
8.4 Asia Pacific Phosphodiesterase (PDE) inhibitors Breakdown Data by Regions
8.4.1 Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Countries
8.4.2 Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Phosphodiesterase (PDE) inhibitors Breakdown Data by Company
9.2 Central & South America Phosphodiesterase (PDE) inhibitors Breakdown Data by Type
9.3 Central & South America Phosphodiesterase (PDE) inhibitors Breakdown Data by Application
9.4 Central & South America Phosphodiesterase (PDE) inhibitors Breakdown Data by Countries
9.4.1 Central & South America Phosphodiesterase (PDE) inhibitors Sales by Countries
9.4.2 Central & South America Phosphodiesterase (PDE) inhibitors Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Breakdown Data by Type
10.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Breakdown Data by Application
10.3 Middle East and Africa Phosphodiesterase (PDE) inhibitors Breakdown Data by Countries
10.3.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Countries
10.3.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Phosphodiesterase (PDE) inhibitors
11.1.4 Phosphodiesterase (PDE) inhibitors Product Introduction
11.1.5 Bayer AG Recent Development
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Phosphodiesterase (PDE) inhibitors
11.2.4 Phosphodiesterase (PDE) inhibitors Product Introduction
11.2.5 Eli Lilly and Co. Recent Development
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Phosphodiesterase (PDE) inhibitors
11.3.4 Phosphodiesterase (PDE) inhibitors Product Introduction
11.3.5 GlaxoSmithKline Plc Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Phosphodiesterase (PDE) inhibitors
11.4.4 Phosphodiesterase (PDE) inhibitors Product Introduction
11.4.5 Pfizer Inc. Recent Development
11.5 Vivus Inc.
11.5.1 Vivus Inc. Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Phosphodiesterase (PDE) inhibitors
11.5.4 Phosphodiesterase (PDE) inhibitors Product Introduction
11.5.5 Vivus Inc. Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Phosphodiesterase (PDE) inhibitors Sales Channels
12.2.2 Phosphodiesterase (PDE) inhibitors Distributors
12.3 Phosphodiesterase (PDE) inhibitors Customers

13 Market Forecast
13.1 Global Phosphodiesterase (PDE) inhibitors Sales and Revenue Forecast 2019-2025
13.2 Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Type
13.3 Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Application
13.4 Phosphodiesterase (PDE) inhibitors Forecast by Regions
13.4.1 Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Regions 2019-2025
13.4.2 Global Phosphodiesterase (PDE) inhibitors Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Phosphodiesterase (PDE) inhibitors Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Phosphodiesterase (PDE) inhibitors Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Phosphodiesterase (PDE) inhibitors Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Phosphodiesterase (PDE) inhibitors Product Picture
Table Phosphodiesterase (PDE) inhibitors Key Market Segments
Table Major Manufacturers Phosphodiesterase (PDE) inhibitors Covered in This Report
Table Global Phosphodiesterase (PDE) inhibitors Market Size Growth Rate by Type 2019-2025 (K Liter) & (Million US$)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Market Shar by Type 2014-2025
Figure PDE1 Selective Inhibitors Figures
Table Major Manufacturers of PDE1 Selective Inhibitors
Figure PDE2 Selective Inhibitors Figures
Table Major Manufacturers of PDE2 Selective Inhibitors
Figure PDE3 Selective Inhibitors Figures
Table Major Manufacturers of PDE3 Selective Inhibitors
Figure PDE4 selective inhibitors Figures
Table Major Manufacturers of PDE4 selective inhibitors
Figure PDE5 selective inhibitors Figures
Table Major Manufacturers of PDE5 selective inhibitors
Figure PDE7 selective inhibitors Figures
Table Major Manufacturers of PDE7 selective inhibitors
Figure PDE10 selective inhibitors Figures
Table Major Manufacturers of PDE10 selective inhibitors
Table Global Phosphodiesterase (PDE) inhibitors Market Share by Application 2019-2025 (K Liter)
Figure Oral Use Case
Figure Topical Use Case
Figure Other Use Case
Figure Phosphodiesterase (PDE) inhibitors Report Years Considered
Figure Global Phosphodiesterase (PDE) inhibitors Market Size 2014-2025 (Million US$)
Figure Global Phosphodiesterase (PDE) inhibitors Sales 2014-2019 (K Liter)
Table Global Phosphodiesterase (PDE) inhibitors Market Size by Regions 2014-2019 (K Liter) & (Million US$)
Table Global Phosphodiesterase (PDE) inhibitors Sales by Regions 2014-2019 (K Liter)
Table Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Regions 2014-2019
Figure Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Regions 2014-2019
Figure Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Regions in 2018
Table Global Phosphodiesterase (PDE) inhibitors Revenue by Regions 2014-2019 (Million US$)
Table Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Regions 2014-2019
Figure Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Regions 2014-2019
Figure Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Phosphodiesterase (PDE) inhibitors Sales by Manufacturers (2014-2019) (K Liter)
Table Global Phosphodiesterase (PDE) inhibitors Sales Share by Manufacturers (2014-2019)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Share by Manufacturers in 2018
Table Phosphodiesterase (PDE) inhibitors Revenue by Manufacturers (2014-2019) (Million USD)
Table Phosphodiesterase (PDE) inhibitors Revenue Share by Manufacturers (2014-2019)
Figure Phosphodiesterase (PDE) inhibitors Value Share by Manufacturers in 2018
Table Global Phosphodiesterase (PDE) inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Phosphodiesterase (PDE) inhibitors Price (2014-2019) (USD/Liter)
Table Key Manufacturers Phosphodiesterase (PDE) inhibitors Plants/Factories Distribution
Table Key Manufacturers Phosphodiesterase (PDE) inhibitors Area Served
Table Date of Key Manufacturers Enter into Phosphodiesterase (PDE) inhibitors Market
Table Key Manufacturers Phosphodiesterase (PDE) inhibitors Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global PDE1 Selective Inhibitors Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global PDE2 Selective Inhibitors Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global PDE3 Selective Inhibitors Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global PDE4 selective inhibitors Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global PDE5 selective inhibitors Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global PDE7 selective inhibitors Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global PDE10 selective inhibitors Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global Phosphodiesterase (PDE) inhibitors Sales by Type (2014-2019) (K Liter)
Table Global Phosphodiesterase (PDE) inhibitors Sales Share by Type (2014-2019)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2014-2019)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2018
Table Global Phosphodiesterase (PDE) inhibitors Revenue by Type (2014-2019) (Million US$)
Table Global Phosphodiesterase (PDE) inhibitors Revenue Share by Type (2014-2019)
Figure Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Type (2014-2019)
Figure Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Type in 2018
Table Phosphodiesterase (PDE) inhibitors Price by Type 2014-2019 (USD/Liter)
Table Global Phosphodiesterase (PDE) inhibitors Sales by Application (2014-2019) (K Liter)
Table Global Phosphodiesterase (PDE) inhibitors Sales Share by Application (2014-2019)
Figure Global Sales Phosphodiesterase (PDE) inhibitors Market Share by Application (2014-2019)
Figure Global Sales Phosphodiesterase (PDE) inhibitors Market Share by Application in 2018
Figure North America Phosphodiesterase (PDE) inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure North America Phosphodiesterase (PDE) inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table North America Phosphodiesterase (PDE) inhibitors Sales by Company (2014-2019) (K Liter)
Table North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Company (2014-2019)
Figure North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Company in 2018
Table North America Phosphodiesterase (PDE) inhibitors Sales by Type (2014-2019) (K Liter)
Table North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2014-2019)
Figure North America Phosphodiesterase (PDE) inhibitors Market Share by Type in 2018
Table North America Phosphodiesterase (PDE) inhibitors Sales by Application (2014-2019) (K Liter)
Table North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2014-2019)
Figure North America Phosphodiesterase (PDE) inhibitors Market Share by Application in 2018
Table North America Phosphodiesterase (PDE) inhibitors Sales by Countries (2014-2019) (K Liter)
Table North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Countries (2014-2019)
Figure North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Countries in 2018
Table North America Phosphodiesterase (PDE) inhibitors Revenue by Countries (2014-2019) (Million US$)
Table North America Phosphodiesterase (PDE) inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Phosphodiesterase (PDE) inhibitors Revenue Market Share by Countries in 2018
Figure United States Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Canada Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Mexico Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Europe Phosphodiesterase (PDE) inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Europe Phosphodiesterase (PDE) inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Phosphodiesterase (PDE) inhibitors Sales by Company (2014-2019) (K Liter)
Table Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Company (2014-2019)
Figure Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Company in 2018
Table Europe Phosphodiesterase (PDE) inhibitors Sales by Type (2014-2019) (K Liter)
Table Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2014-2019)
Figure Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2018
Table Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2014-2019) (K Liter)
Table Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2014-2019)
Figure Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2018
Table Europe Phosphodiesterase (PDE) inhibitors Sales by Countries (2014-2019) (K Liter)
Table Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Countries (2014-2019)
Figure Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Countries in 2018
Table Europe Phosphodiesterase (PDE) inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Europe Phosphodiesterase (PDE) inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe Phosphodiesterase (PDE) inhibitors Revenue Market Share by Countries in 2018
Figure Germany Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure France Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure UK Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Italy Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Russia Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Regions (2014-2019) (K Liter)
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Regions in 2018
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Type (2014-2019) (K Liter)
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2014-2019)
Figure Asia Pacific Phosphodiesterase (PDE) inhibitors Market Share by Type in 2018
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Application (2014-2019) (K Liter)
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2014-2019)
Figure Asia Pacific Phosphodiesterase (PDE) inhibitors Market Share by Application in 2018
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Countries (2014-2019) (K Liter)
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Regions in 2018
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue Market Share by Regions in 2018
Figure China Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure China Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Japan Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Korea Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure India Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure India Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Australia Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Indonesia Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Malaysia Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Philippines Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Thailand Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Vietnam Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Phosphodiesterase (PDE) inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Central & South America Phosphodiesterase (PDE) inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Phosphodiesterase (PDE) inhibitors Sales by Company (2014-2019) (K Liter)
Table Central & South America Phosphodiesterase (PDE) inhibitors Sales Market Share by Company (2014-2019)
Figure Central & South America Phosphodiesterase (PDE) inhibitors Sales Market Share by Company in 2018
Table Central & South America Phosphodiesterase (PDE) inhibitors Sales by Type (2014-2019) (K Liter)
Table Central & South America Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2014-2019)
Figure Central & South America Phosphodiesterase (PDE) inhibitors Market Share by Type in 2018
Table Central & South America Phosphodiesterase (PDE) inhibitors Sales by Application (2014-2019) (K Liter)
Table Central & South America Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2014-2019)
Figure Central & South America Phosphodiesterase (PDE) inhibitors Market Share by Application in 2018
Table Central & South America Phosphodiesterase (PDE) inhibitors Sales by Countries (2014-2019) (K Liter)
Table Central & South America Phosphodiesterase (PDE) inhibitors Sales Market Share by Countries (2014-2019)
Figure Central & South America Phosphodiesterase (PDE) inhibitors Sales Market Share by Countries in 2018
Table Central & South America Phosphodiesterase (PDE) inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Phosphodiesterase (PDE) inhibitors Revenue Market Share by Countries (2014-2019)
Figure Central & South America Phosphodiesterase (PDE) inhibitors Revenue Market Share by Countries in 2018
Figure Brazil Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Brazil Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Figure Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Type (2014-2019) (K Liter)
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2018
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Application (2014-2019) (K Liter)
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2018
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Countries (2014-2019) (K Liter)
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Countries in 2018
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue Market Share by Countries in 2018
Figure GCC Countries Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure GCC Countries Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Figure Egypt Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Egypt Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Figure South Africa Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure South Africa Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Table Bayer AG Company Details
Table Bayer AG Description and Business Overview
Table Bayer AG Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table Bayer AG Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019)
Table Bayer AG Phosphodiesterase (PDE) inhibitors Sales Market Share in Global Market
Table Bayer AG Recent Development
Table Eli Lilly and Co. Company Details
Table Eli Lilly and Co. Description and Business Overview
Table Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019)
Table Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales Market Share in Global Market
Table Eli Lilly and Co. Recent Development
Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Description and Business Overview
Table GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales Market Share in Global Market
Table GlaxoSmithKline Plc Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Description and Business Overview
Table Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019)
Table Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales Market Share in Global Market
Table Pfizer Inc. Recent Development
Table Vivus Inc. Company Details
Table Vivus Inc. Description and Business Overview
Table Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2014-2019)
Table Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales Market Share in Global Market
Table Vivus Inc. Recent Development
Figure Phosphodiesterase (PDE) inhibitors Value Chain
Table Phosphodiesterase (PDE) inhibitors Distributors List
Table Phosphodiesterase (PDE) inhibitors Customers List
Table Global Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter) & (Million US$)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Global Phosphodiesterase (PDE) inhibitors Revenue Forecast 2019-2025 (Million US$)
Table Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Type 2019-2025 (K Liter)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Type 2019-2025 (K Liter)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Type 2019-2025
Table Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Application 2019-2025 (K Liter)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Application 2019-2025 (K Liter)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Application 2019-2025
Table Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Figure Global Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Global Phosphodiesterase (PDE) inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Phosphodiesterase (PDE) inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Phosphodiesterase (PDE) inhibitors Revenue Market Share Forecast by Regions 2019-2025
Table North America Phosphodiesterase (PDE) inhibitors Sales Forecast by Countries 2019-2025 (K Liter)
Table North America Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Countries 2019-2025
Table North America Phosphodiesterase (PDE) inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Phosphodiesterase (PDE) inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure United States Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Canada Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Mexico Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Table Europe Phosphodiesterase (PDE) inhibitors Sales Forecast by Countries 2019-2025 (K Liter)
Table Europe Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Countries 2019-2025
Table Europe Phosphodiesterase (PDE) inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Phosphodiesterase (PDE) inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure France Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure UK Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Italy Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Russia Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue Market Share Forecast by Regions 2019-2025
Figure China Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Japan Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure South Korea Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure India Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Australia Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Indonesia Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Thailand Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Malaysia Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Philippines Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Vietnam Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Table Central & South America Phosphodiesterase (PDE) inhibitors Sales Forecast by Countries 2019-2025 (K Liter)
Table Central & South America Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Phosphodiesterase (PDE) inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Phosphodiesterase (PDE) inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure GCC Countries Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Egypt Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Figure South Africa Phosphodiesterase (PDE) inhibitors Sales Forecast 2019-2025 (K Liter)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bayer AG、Eli Lilly and Co.、GlaxoSmithKline Plc、Pfizer Inc.、Vivus Inc.

★調査レポート[世界のホスホジエステラーゼ（PDE）阻害剤産業：成長傾向・競合分析2019-2025] (コード：DATA909X01764)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のホスホジエステラーゼ（PDE）阻害剤産業：成長傾向・競合分析2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のヤヌスキナーゼ（JAK）阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X01275 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界のヤヌスキナーゼ（JAK）阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ヤヌスキナーゼ（JAK）阻害剤の種類別には、自己免疫疾患、腫瘍学に、用途別には、クリニック、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・ヤヌスキナーゼ（JAK）阻害剤の種類別市場規模：自己免疫疾患、腫瘍学 ・ヤヌスキナーゼ（JAK）阻害剤の用途別市場規模：クリニック、病院 ・ヤヌスキナーゼ（JAK）阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Astellas Pharma, Inc.、Eli...Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.In 2018, the global Janus Kinase (JAK) Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Janus Kinase (JAK) Inhibitors. This study researches the market...
  • 世界のMEK阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X01476 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界のMEK阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。MEK阻害剤の種類別には、メキニスト、コテリック、メクトビに、用途別には、NSCLC、がんに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・MEK阻害剤の種類別市場規模：メキニスト、コテリック、メクトビ ・MEK阻害剤の用途別市場規模：NSCLC、がん ・MEK阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：AstraZeneca Plc、F. Hoffmann-La...A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.In 2018, the global MEK Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for MEK Inhibitors. This study researches the market size of MEK Inhibitors, presents the global MEK Inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2014...
  • 世界のBRAFキナーゼ阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X00353 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界のBRAFキナーゼ阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。BRAFキナーゼ阻害剤の種類別には、ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブに、用途別には、病院、医学研究所、クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・BRAFキナーゼ阻害剤の種類別市場規模：ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブ ・BRAFキナーゼ阻害剤の用途別市場規模：病院、医学研究所、クリニック、その他 ・BRAFキナーゼ阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Array BioPharma Inc.、Bayer...BRAF kinase inhibitors are generally used as targeted therapy drugs for the treatment of carcinomas such as RCC, NSCLC, and melanomas caused by mutations of the BRAF gene.These drugs directly target BRAF protein and inhibit the growth of tumors in patients with metastatic melanoma. Such results delivered by the BRAF kinase inhibitors has encouraged several R&D teams to extend research on other applications. Moreover, many BRAF kinase inhibitor drugs are in the final stages of development and are expected to be launched during the forecast period. In 2018, the global BRAF Kinase Inhibitors market size was xx million US$ and...
  • 世界の有毛細胞白血病治療産業：成長傾向・競合分析2019-2025
    DATA909X01057 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の有毛細胞白血病治療市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。有毛細胞白血病治療の種類別には、化学療法薬、標的阻害剤に、用途別には、クリニック、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・有毛細胞白血病治療の種類別市場規模：化学療法薬、標的阻害剤 ・有毛細胞白血病治療の用途別市場規模：クリニック、病院 ・有毛細胞白血病治療の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：AstraZeneca Plc、F. Hoffmann-La...Hairy cell leukemia is a slow-growing, rare type of chronic cell leukemia.In 2018, the global Hairy Cell Leukemia Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hairy Cell Leukemia Drugs. This study researches the market size of Hairy Cell Leukemia Drugs, presents the global Hairy Cell Leukemia Drugs sales and revenue by companies, regions, type and application, history breakdown...
  • 世界の皮膚炎薬産業：成長傾向・競合分析2019-2025
    DATA909X00652 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の皮膚炎薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。皮膚炎薬の種類別には、カルシニューリン阻害剤、コルチコステロイド、生物製剤、その他に、用途別には、病院薬局、小売薬局、オンライン薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・皮膚炎薬の種類別市場規模：カルシニューリン阻害剤、コルチコステロイド、生物製剤、その他 ・皮膚炎薬の用途別市場規模：病院薬局、小売薬局、オンライン薬局 ・皮膚炎薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Regeneron、Bausch Health、Astellas Pharma、Pfizer、Mylan、Bayer、Allergan、LEO...Dermatitis, also known as eczema, is a group of diseases that results in inflammation of the skin. These diseases are characterized by itchiness, red skin and a rash.In 2018, the global Dermatitis Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dermatitis Drugs. This study researches the market size of Dermatitis Drugs, presents the global Dermatitis Drugs sales and revenue by companies, regions, type and application, history breakdown...
  • 世界のパラフェニルフェノール産業：成長傾向・競合分析2019-2025
    DATA909X01707 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界のパラフェニルフェノール市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。パラフェニルフェノールの種類別には、純度≥99％、純度...The Para Phenyl Phenol market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Para Phenyl Phenol. This study focuses on the production side and consumption side of Para Phenyl Phenol, presents the global Para Phenyl Phenol market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. In...

    • ◆H&Iグローバルリサーチのお客様（例）◆